Target intelligence / Profile preview

Biological Molecules via aptamer

Molecular classification
Other
01

Overview

Biological Molecules via aptamer refers to a broad class of molecular entities, including proteins, small molecules, and cell-surface receptors, that are specifically recognized and bound by aptamers. Aptamers are short, single-stranded DNA, RNA, or peptide sequences that fold into complex three-dimensional structures, allowing them to function as chemical antibodies. This targeting modality is used in therapeutics to inhibit the function of disease-associated proteins, such as vascular endothelial growth factor (VEGF) in age-related macular degeneration or complement component 5 (C5) in geographic atrophy. Because this term describes a diverse group of targets rather than a single biological entity, it is considered a categorical classification rather than a specific therapeutic target. Aptamer-based targeting offers advantages such as low immunogenicity, high stability, and ease of chemical modification for diagnostic and therapeutic applications.

Other names
Aptamer targetsNucleic acid aptamer targetsPeptide aptamer targetsAptamer-binding molecules
02

Mechanism of action

Aptamers bind to their target molecules with high affinity and specificity, typically acting as antagonists to block protein-protein or protein-ligand interactions, or as delivery vehicles for other therapeutic agents.

03

Biological functions

Signal transductionCell-cell communicationEnzymatic activityImmune response
04

Disease associations

CancerMacular degenerationInflammationInfectionCardiovascular disease
05

Safety considerations

Rapid renal clearanceNuclease degradationPotential for off-target bindingPEG-related hypersensitivity
06

Interacting drugs

Pegaptanib

4 more in the full profile.

07

Biomarkers

Target protein concentrationAptamer-target complex levels

Beyond the preview

Go deeper on Biological Molecules via aptamer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biological Molecules via aptamer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call